BiotechTube

TV-1106 + somatropin

Phase 2Terminated
0 watching 0 views this week⚡ Active
49
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Growth Hormone-Deficiency

Conditions

Growth Hormone-Deficiency

Trial Timeline

Apr 30, 2014 → Aug 31, 2016

NCT ID
NCT02092077

About TV-1106 + somatropin

TV-1106 + somatropin is a phase 2 stage product being developed by Teva Pharmaceutical Industries for Growth Hormone-Deficiency. The current trial status is terminated. This product is registered under clinical trial identifier NCT02092077. Target conditions include Growth Hormone-Deficiency.

Hype Score Breakdown

Clinical
17
Activity
12
Company
7
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT02092077Phase 2Terminated

Competing Products

20 competing products in Growth Hormone-Deficiency

See all competitors
ProductCompanyStageHype Score
SomatropinEli LillyPhase 3
77
Somatropin (recombinant deoxyribonucleic acid [rDNA] origin)Eli LillyPre-clinical
23
HER3-DXdDaiichi SankyoPre-clinical
23
ErlotinibAstellas PharmaPhase 2
52
radio-labeled naquotinib + naquotinibAstellas PharmaPhase 1
33
pegylated Somatropin + pegylated Somatropin + Jintropin AQSun PharmaceuticalPhase 2
52
PEG-somatropinSun PharmaceuticalApproved
85
PEG-somatropin + PEG-somatropinSun PharmaceuticalApproved
85
PEG-somatropinSun PharmaceuticalPhase 3
77
Somatropin + SomatropinEli LillyPhase 3
77
Somatropin + SomatropinEli LillyPhase 3
77
somatropin, rDNA origin, for injectionEli LillyPhase 3
77
Sterile becaplermin gel vs. sterile placebo gel treatment 1Johnson & JohnsonPre-clinical
23
ABT-414AbbViePre-clinical
23
Saizen® A + Saizen® BMerckPhase 3
77
Saizen® solution for injection (referred as Saizen®)MerckApproved
85
Cetuximab + FOLFIRI (5-Fluorouracil, Folinic acid, Irinotecan)MerckPhase 3
77
Saizen + SaizenMerckApproved
85
MiransertibMerckPhase 2
52
MiransertibMerckPhase 1/2
41

Other Products from Teva Pharmaceutical Industries

Laquinimod + PlaceboPhase 2
49
40 mg glatiramer acetate + PlaceboPhase 2
49
Hydroxychloroquine (HCQ) + Azithromycin (Azithro) + Placebo for Hydroxychloroquine + Placebo for AzithromycinPhase 2
49
cytarabine + omacetaxine mepesuccinate + decitabinePhase 2
49
Omacetaxine + Azacitidine + G-CSFPhase 1/2
38